GSK drug’s new approval sets up competition with Dupixent

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. Apologies that this newsletter is coming late to you this morning — we had some technical difficulties. But we’ve still got the news for you today.GLP-1